Status:

COMPLETED

Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France

Lead Sponsor:

University Hospital, Lille

Conditions:

Coronavirus

COVID

Eligibility:

All Genders

Up to 18 years

Brief Summary

Arriving in December 2019, Coronavirus COVID-19 infection is causing a global pandemic with high morbidity and mortality among adults and especially seniors. The child appears little or no affected by...

Eligibility Criteria

Inclusion

  • 1st Line Consultation in Pediatric Emergencies
  • All reasons for consultation during working hours
  • Informed and written consent of a parent holder (only 1 authorized companion) and a child of understanding age

Exclusion

  • Refusal of participation by parents/child of decision age
  • No membership of a social security scheme (beneficiary or entitled)
  • No understanding of French

Key Trial Info

Start Date :

April 15 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2021

Estimated Enrollment :

901 Patients enrolled

Trial Details

Trial ID

NCT04336761

Start Date

April 15 2020

End Date

January 1 2021

Last Update

March 11 2021

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

CH Louis MOURIER

Colombes, France

2

Hôpital Jeanne de Flandres, CHU

Lille, France, 59037

3

Hôpital Mère Enfant CHU

Nantes, France

4

Hôpitaux Pédiatriques de Nice CHU-Lenval

Nice, France